STAGRStatic Gradient Survey Report (energy exploration)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
- London, England-based biopharmaceutical company Stallergenes Greer (Paris: STAGR) Japanese partner Shionogi and Co.
Stallergenes Greer's (EPA: STAGR) Japanese partner, Shionogi & Co Ltd (TYO: 4507), has received approval to extend the indication for Actair to treat patients under the age of 12, the company disclosed on Friday.
Stallergenes Greer (Paris: STAGR), a biopharmaceutical company specialising in treatments for respiratory allergies, today published its unaudited net sales for the three-month period ended 31 March 2019.